The Digital Therapeutics Alliance (DTA) is the leading international organization focused on advancing digital therapeutics to enhance clinical and health economic outcomes. Established in 2017, the DTA is a non-profit trade association that brings together industry leaders and stakeholders to promote the understanding, adoption, and integration of clinically evaluated digital therapeutics with patients, clinicians, payors, and policymakers.

DTA provides essential tools to evaluate and utilize digital therapeutic products and aims to broaden the understanding of DTx through education, advocacy, and cross-industry collaboration. The organization offers a range of resources, including the DTx Evaluation Toolkit, a Product Library, and DTx by Country information. Additionally, DTA engages with a diverse community of members and resource partners to drive its mission forward.

Through its Board of Directors and dedicated team, DTA works to improve clinical and health economic outcomes by advancing the use of high-quality, evidence-based digital therapeutics worldwide. Join the DTA community and stay updated with the latest news, articles, and resources related to digital therapeutics.